KelaHealth to Showcase Surgical Risk Prediction Technology at HLTH 2021

On October 17-20, the HLTH 2021 conference in Boston, Massachusetts will bring together healthcare leaders, technology companies, investors, and policymakers to address emerging health innovations.

LinkedIn post HLTH_Updated

Dr. Bora Chang, CEO and founder of KelaHealth, will be showcasing our unique, data-driven approach to reducing surgical complications and adverse events.  Historically,  it has been difficult to impact surgical quality using traditional process improvement methods.  Surgeons make a handful of highly subjective decisions that significantly impact patient outcomes, often based on very little data

The KelaHealth surgical intelligence platform applies the latest artificial intelligence and machine learning techniques to risk-stratify each patient prior to their procedure and deliver personalized intervention recommendations at the point of care, throughout the surgical journey.

Our results, published in peer-reviewed journals, demonstrate the power of predictive analytics to drive better decisions and reduce surgical costs. Our proprietary tracking and outcomes reports support sustainable, meaningful change in patient care across multiple surgical disciplines.

If you will be attending HLTH 2021, come visit us at the KelaHealth kiosk in the Cedars-Sinai Accelerator area (Booth #757-8). If you won’t be able to make it to Boston this year, contact us to schedule a time for us to connect. We look forward to hearing your needs, challenges, and ideas around surgical quality.  We believe we can do better - together.

2023: Put it in the books! A Kela-Year Chock Full of New Partners and Game-Changing Evidence

As we reflect on 2023, it is both exciting and surprising to see how much has been accomplished to advance KelaHealth’s strategic initiatives in just one year. We have launched ...

AI is Emerging as a Game Changer in Outpatient Orthopedic Surgery

Authors: Alan Young MD, MBA, Head of Clinical Partnerships, Gina Della Porta, DHSc, MHS, Director of Research, Joie Cooney, Head of Commercial, KelaHealth Ahead of the American ...

Using Artificial Intelligence (AI) to Manage Patient Flow in Surgery as the COVID-19 Delta Variant Surges

How can you identify lower-risk patients and safely plan for outpatient surgery or less intensive post-surgical care? By Joie Cooney, Head of Commercial, and Gina Della Porta, ...